Receptor, Angiotensin, Type 2
"Receptor, Angiotensin, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR.
MeSH Number(s)
D12.776.543.750.100.047.687
D12.776.543.750.720.600.150.687
D12.776.543.750.750.130.875
D12.776.543.750.750.555.150.875
Concept/Terms
Receptor, Angiotensin, Type 2- Receptor, Angiotensin, Type 2
- Angiotensin II Type 2 Receptor
- Receptor, Angiotensin II Type 2
- Angiotensin AT2 Receptor
- AT2 Receptor, Angiotensin
- Receptor, Angiotensin AT2
- Angiotensin Type 2 Receptor
Below are MeSH descriptors whose meaning is more general than "Receptor, Angiotensin, Type 2".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.100]
- Receptors, Angiotensin [D12.776.543.750.100.047]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.100.047.687]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Angiotensin [D12.776.543.750.720.600.150]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.720.600.150.687]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Angiotensin [D12.776.543.750.750.130]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.750.130.875]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Angiotensin [D12.776.543.750.750.555.150]
- Receptor, Angiotensin, Type 2 [D12.776.543.750.750.555.150.875]
Below are MeSH descriptors whose meaning is more specific than "Receptor, Angiotensin, Type 2".
This graph shows the total number of publications written about "Receptor, Angiotensin, Type 2" by people in Harvard Catalyst Profiles by year, and whether "Receptor, Angiotensin, Type 2" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 2 | 2 |
1998 | 0 | 4 | 4 |
1999 | 0 | 6 | 6 |
2000 | 0 | 4 | 4 |
2001 | 0 | 3 | 3 |
2002 | 0 | 2 | 2 |
2003 | 1 | 0 | 1 |
2004 | 2 | 2 | 4 |
2005 | 3 | 0 | 3 |
2007 | 0 | 3 | 3 |
2008 | 2 | 1 | 3 |
2009 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2013 | 0 | 2 | 2 |
2014 | 0 | 1 | 1 |
2017 | 2 | 0 | 2 |
2018 | 2 | 0 | 2 |
2020 | 0 | 2 | 2 |
2021 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Receptor, Angiotensin, Type 2" by people in Profiles.
-
Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1-7)/MasR signaling in normal and hypertensive pregnancy. Biochem Pharmacol. 2024 Feb; 220:115963.
-
Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice. Clin Sci (Lond). 2022 05 27; 136(10):715-731.
-
Delayed Administration of Angiotensin Receptor (AT2R) Agonist C21 Improves Survival and Preserves Sensorimotor Outcomes in Female Diabetic Rats Post-Stroke through Modulation of Microglial Activation. Int J Mol Sci. 2021 Jan 29; 22(3).
-
Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury. Kidney Int. 2021 01; 99(1):148-160.
-
A current review of COVID-19 for the cardiovascular specialist. Am Heart J. 2020 08; 226:29-44.
-
Differential Expression of Renin-Angiotensin System-related Components in Patients with Rheumatoid Arthritis and Osteoarthritis. Am J Med Sci. 2020 01; 359(1):17-26.
-
AT2R (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the Rat. Hypertension. 2018 09; 72(3):e20-e29.
-
The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome. J Cardiovasc Pharmacol. 2018 04; 71(4):215-222.
-
Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice. Endocrinology. 2018 02 01; 159(2):836-852.
-
AT2 R deficiency mediated podocyte loss via activation of ectopic hedgehog interacting protein (Hhip) gene expression. J Pathol. 2017 11; 243(3):279-293.